학술논문
Effectiveness and safety of switching from fingolimod and natalizumab to rituximab in patients with relapsing remitting multiple sclerosis
Document Type
Article
Source
In Multiple Sclerosis and Related Disorders March 2023 71
Subject
Language
ISSN
2211-0348